Babylon Holdings Limited (BBLNF)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 12, 2025, 11:35 AM EDT
Exscientia Revenue
Babylon Holdings had revenue of $311.12M in the quarter ending March 31, 2023, with 16.77% growth. This brings the company's revenue in the last twelve months to $1.15B, up 123.72% year-over-year. In the year 2022, Babylon Holdings had annual revenue of $1.11B with 245.88% growth.
Revenue (ttm)
1.15B
Revenue Growth
+123.72%
P/S Ratio
n/a
Revenue / Employee
609.15K
Employees
1,895
Market Cap
2.56K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 1.11B | 788.84M | 245.88% |
| Dec 31, 2021 | 320.83M | 241.56M | 304.72% |
| Dec 31, 2020 | 79.27M | 63.24M | 394.40% |
| Dec 31, 2019 | 16.03M | 9.72M | 153.85% |
| Dec 31, 2018 | 6.32M | 3.87M | 158.18% |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |
Babylon Holdings News
- 2 years ago - Babylon In Discussions of New Strategic Alternatives for its Businesses - Business Wire